Skip to main content
Top

22-03-2024 | Original Article

Warthin’s Tumour as a Parotid Gland Incidentaloma Identified by PET–CT Scan in a Large Series of Cases

Authors: Anna Holgado, Xavier León, Albert Llansana, Cristina Valero, Maria Casasayas, Alejandro Fernandez-León, Miquel Quer

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery

Login to get access

Abstract

Occasionally in imaging scans there are findings unrelated to the pathology for which the scan was indicated, findings that are called incidentalomas. Warthin tumors have a high glucose avidity, being one of the common incidentalomas in PET–CT scans. The aim of the present study is to analyze the frequency of occurrence of Warthin’s tumor as an incidental finding in a large series of patients undergoing 18F-FDG PET–CT. Retrospective analysis of 18F-FDG PET–CT scans performed in our center during the period 2010–2021. Parotid hypermetabolic lesions were identified, as well as their SUVmax, size, smoking habit, BMI (body mass index), and otorhinolaryngology follow-up. 31,423 PET–CT-18FDG studies corresponding to 12,806 patients were analyzed. The frequency of incidentalomas at the parotid level with a diagnosis compatible with Warthin’s tumor was 0.87% (n = 111). Eighty percent of the patients with incidentalomas accordant to Warthin’s tumor had a history of tobacco use. The highest percentage of incidentalomas compatible with a Warthin tumor was found in patients in whom the indication for PET–CT was the study of a lung carcinoma (1.44%). Only 37% of patients with a PET–CT lesion compatible with a Warthin’s tumor were referred for evaluation by the Otorhinolaryngology service. The incidence of Warthin’s tumor in 18-FDG PET–CT scans in our center was 0.87%.
Literature
1.
go back to reference Quer M, Hernandez-Prera JC, Silver CE, Casasayas M, Simo R, Vander Poorten V et al (2021) Current trends and controversies in the management of Warthin tumor of the parotid gland. Diagnostics (Basel) 11(8):1467CrossRefPubMed Quer M, Hernandez-Prera JC, Silver CE, Casasayas M, Simo R, Vander Poorten V et al (2021) Current trends and controversies in the management of Warthin tumor of the parotid gland. Diagnostics (Basel) 11(8):1467CrossRefPubMed
2.
go back to reference Yanes-Diaz J, Riestra-Ayora J, Rodriguez-Rivero A, Yebra-Gonzalez L, Chaure-Cordero M, Vaduva C et al (2022) Trend changes in the incidence of benign parotid tumours in the last 30 years in a Spanish population. Eur Arch Otorhinolaryngol 280(2):855–860CrossRefPubMed Yanes-Diaz J, Riestra-Ayora J, Rodriguez-Rivero A, Yebra-Gonzalez L, Chaure-Cordero M, Vaduva C et al (2022) Trend changes in the incidence of benign parotid tumours in the last 30 years in a Spanish population. Eur Arch Otorhinolaryngol 280(2):855–860CrossRefPubMed
3.
go back to reference Mantsopoulos K, Iro H (2020) Pleomorphic adenoma compared with cystadenolymphoma of the parotid gland: which is more common? Br J Oral Maxillofac Surg 58(3):361–363CrossRefPubMed Mantsopoulos K, Iro H (2020) Pleomorphic adenoma compared with cystadenolymphoma of the parotid gland: which is more common? Br J Oral Maxillofac Surg 58(3):361–363CrossRefPubMed
4.
go back to reference Franzen AM, Kaup Franzen C, Guenzel T, Lieder A (2018) Correction to: increased incidence of Warthin tumours of the parotid gland: a 42-year evaluation. Eur Arch Otorhinolaryngol 275(10):2599CrossRefPubMed Franzen AM, Kaup Franzen C, Guenzel T, Lieder A (2018) Correction to: increased incidence of Warthin tumours of the parotid gland: a 42-year evaluation. Eur Arch Otorhinolaryngol 275(10):2599CrossRefPubMed
5.
go back to reference Horiuchi M, Yasuda S, Shohtsu A, Ide M (1998) Four cases of Warthin’s tumor of the parotid gland detected with FDG PET. Ann Nucl Med 12:47–50CrossRefPubMed Horiuchi M, Yasuda S, Shohtsu A, Ide M (1998) Four cases of Warthin’s tumor of the parotid gland detected with FDG PET. Ann Nucl Med 12:47–50CrossRefPubMed
6.
go back to reference Okamura T, Kawabe J, Koyama K, Ochi H, Yamada R, Sakamoto H et al (1998) Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol 118(538):209–213CrossRef Okamura T, Kawabe J, Koyama K, Ochi H, Yamada R, Sakamoto H et al (1998) Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol 118(538):209–213CrossRef
7.
go back to reference Rassekh CH, Cost JL, Hogg JP, Hurst MK, Marano GD, Ducatman BS (2015) Positron emission tomography in Warthin’s tumor mimicking malignancy impacts the evaluation of head and neck patients. Am J Otolaryngol - Head Neck Med Surg 36(2):259–263 Rassekh CH, Cost JL, Hogg JP, Hurst MK, Marano GD, Ducatman BS (2015) Positron emission tomography in Warthin’s tumor mimicking malignancy impacts the evaluation of head and neck patients. Am J Otolaryngol - Head Neck Med Surg 36(2):259–263
8.
go back to reference Higashi T, Murahashi H, Ikuta H, Mori Y, Watanabe Y (1987) Identification of Warthin’s tumor with technetium-99m pertechnetate. Clin Nucl Med 12(10):796–800CrossRefPubMed Higashi T, Murahashi H, Ikuta H, Mori Y, Watanabe Y (1987) Identification of Warthin’s tumor with technetium-99m pertechnetate. Clin Nucl Med 12(10):796–800CrossRefPubMed
9.
go back to reference Seifert G, Bull HG, Donath K (1980) Histologic subclassification of the cystadenolymphoma of the parotid gland. Analysis of 275 cases. Virchows Arch A Pathol Anat Histol 388(1):13–38CrossRefPubMed Seifert G, Bull HG, Donath K (1980) Histologic subclassification of the cystadenolymphoma of the parotid gland. Analysis of 275 cases. Virchows Arch A Pathol Anat Histol 388(1):13–38CrossRefPubMed
10.
go back to reference Minamimoto R (2021) Proliferation PET/CT imaging of salivary gland tumor. Diagnostics (Basel) 11(11):2065CrossRefPubMed Minamimoto R (2021) Proliferation PET/CT imaging of salivary gland tumor. Diagnostics (Basel) 11(11):2065CrossRefPubMed
11.
go back to reference Allegra SR (1971) Warthin’s tumor: a hypersensitivity disease? Ultrastructural, light, and immunofluorescent study. Hum Pathol 2(3):403–420CrossRefPubMed Allegra SR (1971) Warthin’s tumor: a hypersensitivity disease? Ultrastructural, light, and immunofluorescent study. Hum Pathol 2(3):403–420CrossRefPubMed
12.
go back to reference Foulsham CK, Johnson GS, Snyder GG, Carpenter RJ, Shafi NQ (1984) Immunohistopathology of papillary cystadenoma lymphomatosum (Warthin’s tumor). Ann Clin Lab Sci 14(1):47–63PubMed Foulsham CK, Johnson GS, Snyder GG, Carpenter RJ, Shafi NQ (1984) Immunohistopathology of papillary cystadenoma lymphomatosum (Warthin’s tumor). Ann Clin Lab Sci 14(1):47–63PubMed
13.
go back to reference Lewis PD, Baxter P, Griffiths AP, Parry JM, Skibinski DOF, Lewis P (2000) Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin’s tumour. J Pathol 191(3):274–281CrossRefPubMed Lewis PD, Baxter P, Griffiths AP, Parry JM, Skibinski DOF, Lewis P (2000) Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin’s tumour. J Pathol 191(3):274–281CrossRefPubMed
14.
go back to reference Ohashi T, Lnoue N, Aoki M (2020) The Warburg effect and M2 macrophage polarization in head and neck cancer. Gan To Kagaku Ryoho 47(1):6–10PubMed Ohashi T, Lnoue N, Aoki M (2020) The Warburg effect and M2 macrophage polarization in head and neck cancer. Gan To Kagaku Ryoho 47(1):6–10PubMed
15.
go back to reference Horiuchi C, Tsukuda M, Taguchi T, Ishiguro Y, Okudera K, Inoue T (2008) Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas. Ann Nucl Med 22(8):693–698CrossRefPubMed Horiuchi C, Tsukuda M, Taguchi T, Ishiguro Y, Okudera K, Inoue T (2008) Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas. Ann Nucl Med 22(8):693–698CrossRefPubMed
16.
go back to reference Mandic R, Agaimy A, Pinto-Quintero D, Roth K, Teymoortash A, Schwarzbach H et al (2020) Aberrant expression of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) in Warthin tumors. Cancers (Basel) 12(5):1112CrossRefPubMed Mandic R, Agaimy A, Pinto-Quintero D, Roth K, Teymoortash A, Schwarzbach H et al (2020) Aberrant expression of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) in Warthin tumors. Cancers (Basel) 12(5):1112CrossRefPubMed
17.
go back to reference Vera-Sirera B, Pérez-Rojas J, López-Valdivia C, Jiménez E, Collado-Martín D, Vera-Sempere F (2011) Expresión de SDHB en el tumor de Warthin. Acta Otorrinolaringol Esp 62(5):355–362CrossRefPubMed Vera-Sirera B, Pérez-Rojas J, López-Valdivia C, Jiménez E, Collado-Martín D, Vera-Sempere F (2011) Expresión de SDHB en el tumor de Warthin. Acta Otorrinolaringol Esp 62(5):355–362CrossRefPubMed
18.
go back to reference Kadletz L, Grasl S, Perisanidis C, Grasl MC, Erovic BM (2019) Rising incidences of Warthin’s tumors may be linked to obesity: a single-institutional experience. Eur Arch Otorhinolaryngol 276(4):1191–1196CrossRefPubMed Kadletz L, Grasl S, Perisanidis C, Grasl MC, Erovic BM (2019) Rising incidences of Warthin’s tumors may be linked to obesity: a single-institutional experience. Eur Arch Otorhinolaryngol 276(4):1191–1196CrossRefPubMed
19.
20.
go back to reference Danstrup CS, Lyhne NM, Kovacsne A, Fisker R, Zacho HD (2022) Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography. Eur Arch Otorhinolaryngol [Internet] Available from 2022 Sep 18 https://pubmed.ncbi.nlm.nih.gov/35939059/ Danstrup CS, Lyhne NM, Kovacsne A, Fisker R, Zacho HD (2022) Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography. Eur Arch Otorhinolaryngol [Internet] Available from 2022 Sep 18 https://​pubmed.​ncbi.​nlm.​nih.​gov/​35939059/​
23.
go back to reference Klussmann JP, Wittekindt C, Preuss SF, Al Attab A, Schroeder U, Guntinas-Lichius O (2009) High risk for bilateral Warthin tumor in heavy smokers–review of 185 cases. Acta otolaryngol 126(11):1213–1217CrossRef Klussmann JP, Wittekindt C, Preuss SF, Al Attab A, Schroeder U, Guntinas-Lichius O (2009) High risk for bilateral Warthin tumor in heavy smokers–review of 185 cases. Acta otolaryngol 126(11):1213–1217CrossRef
24.
go back to reference Sadetzki S, Oberman B, Mandelzweig L, Chetrit A, Ben-Tal T, Jarus-Hakak A et al (2008) Smoking and risk of parotid gland tumors: a nationwide case-control study. Cancer 112(9):1974–1982CrossRefPubMed Sadetzki S, Oberman B, Mandelzweig L, Chetrit A, Ben-Tal T, Jarus-Hakak A et al (2008) Smoking and risk of parotid gland tumors: a nationwide case-control study. Cancer 112(9):1974–1982CrossRefPubMed
25.
go back to reference Pinkston JA, Cole P (1996) Cigarette smoking and Warthin’s tumor. Am J Epidemiol 144(2):183–187CrossRefPubMed Pinkston JA, Cole P (1996) Cigarette smoking and Warthin’s tumor. Am J Epidemiol 144(2):183–187CrossRefPubMed
26.
go back to reference Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T et al (2005) Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med 30(3):170–176CrossRefPubMed Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T et al (2005) Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med 30(3):170–176CrossRefPubMed
27.
go back to reference Lee SK, Rho BH, Won KS (2009) Parotid incidentaloma identified by combined 18F-fluorodeoxyglucose whole-body positron emission tomography and computed tomography: findings at grayscale and power doppler ultrasonography and ultrasound-guided fine-needle aspiration biopsy or core-needle biopsy. Eur Radiol 19(9):2268–2274CrossRefPubMed Lee SK, Rho BH, Won KS (2009) Parotid incidentaloma identified by combined 18F-fluorodeoxyglucose whole-body positron emission tomography and computed tomography: findings at grayscale and power doppler ultrasonography and ultrasound-guided fine-needle aspiration biopsy or core-needle biopsy. Eur Radiol 19(9):2268–2274CrossRefPubMed
28.
go back to reference Psychogios G, Vlastos I, Thölken R, Zenk J (2020) Warthin’s tumour seems to be the most common benign neoplasm of the parotid gland in Germany. Eur Arch Otorhinolaryngol 277(7):2081–2084CrossRefPubMed Psychogios G, Vlastos I, Thölken R, Zenk J (2020) Warthin’s tumour seems to be the most common benign neoplasm of the parotid gland in Germany. Eur Arch Otorhinolaryngol 277(7):2081–2084CrossRefPubMed
29.
go back to reference Gontarz M, Bargiel J, Gąsiorowski K, Marecik T, Szczurowski P, Zapała J et al (2021) Epidemiology of primary epithelial salivary gland tumors in southern Poland-a 26-year, clinicopathologic retrospective analysis. J Clin Med 10(8):1663CrossRefPubMedPubMedCentral Gontarz M, Bargiel J, Gąsiorowski K, Marecik T, Szczurowski P, Zapała J et al (2021) Epidemiology of primary epithelial salivary gland tumors in southern Poland-a 26-year, clinicopathologic retrospective analysis. J Clin Med 10(8):1663CrossRefPubMedPubMedCentral
30.
go back to reference Makis W, Ciarallo A, Gotra A (2015) Clinical significance of parotid gland incidentalomas on (18)F-FDG PET/CT. Clin Imaging 39(4):667–671CrossRefPubMed Makis W, Ciarallo A, Gotra A (2015) Clinical significance of parotid gland incidentalomas on (18)F-FDG PET/CT. Clin Imaging 39(4):667–671CrossRefPubMed
Metadata
Title
Warthin’s Tumour as a Parotid Gland Incidentaloma Identified by PET–CT Scan in a Large Series of Cases
Authors
Anna Holgado
Xavier León
Albert Llansana
Cristina Valero
Maria Casasayas
Alejandro Fernandez-León
Miquel Quer
Publication date
22-03-2024
Publisher
Springer India
Published in
Indian Journal of Otolaryngology and Head & Neck Surgery
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-024-04592-0